Drugs for men and women — How important is gender as a risk factor for TdP?
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 119 (2) , 186-194
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Corrigendum to “Characterization of ventricular repolarization in male and female guinea pigs” [J. Mol. Cell. Cardiol. 42 (2007) 357–366]Journal of Molecular and Cellular Cardiology, 2008
- Characterization of ventricular repolarization in male and female guinea pigsJournal of Molecular and Cellular Cardiology, 2007
- Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+currents of canine Purkinje fibre cardiac action potential: key roles forIKs,β‐adrenoceptor stimulation, pacing rate and genderBritish Journal of Pharmacology, 2006
- Nontranscriptional Regulation of Cardiac Repolarization Currents by TestosteroneCirculation, 2005
- Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de PointesFundamental & Clinical Pharmacology, 2004
- Long QT syndrome and anaesthesiaBritish Journal of Anaesthesia, 2003
- Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTcThe American Journal of Cardiology, 2002
- Sex differences on the electrocardiographic pattern of cardiac repolarization: Possible role of testosteroneAmerican Heart Journal, 2000
- Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brainEndocrinology, 1994